New Market Research Report: India Pharmaceuticals & Healthcare Report Q4 2013
Pharmaceutical firms continue to post varying results in India due to the government's introduction of policies targeting the pharmaceutical industry. These include patent disrespect and pricecontainment policies for both generic and patented drugs. We maintain our bearish view on the sector and highlight that domestic firms with a large exposure to overseas markets will continue to fare well.
View full press release